Blockchain Registration Transaction Record

TransCode Therapeutics Appoints Dr. Phillip D. Zamore to Scientific Advisory Board

TransCode Therapeutics appoints Dr. Phillip D. Zamore, a leading figure in RNA research, to its Scientific Advisory Board, enhancing its cancer therapy programs. The addition of Dr. Zamore underscores the company's commitment to developing innovative RNA therapeutics for metastatic disease.

TransCode Therapeutics Appoints Dr. Phillip D. Zamore to Scientific Advisory Board

This news matters as it highlights a strategic move by TransCode Therapeutics to strengthen its cancer therapy programs with the expertise of Dr. Zamore. The addition of such a prominent figure in RNA research signifies the company's commitment to advancing innovative RNA therapeutics for the treatment of metastatic disease, potentially offering new hope for cancer patients.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0x7c1235fbb6c3c9f9be684d408d72c50995f7e935b3251df85b82816a495a077c
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintelleVXCO-7ecf91e8454bb81c714e30372f6b2277